Greystone Research Associates is pleased to announce the publication of a new market study. ‘Transdermal Drug Patches: Products, Indications, Markets and Forecasts’ is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the drug delivery sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for prescription drugs packaged and supplied in transdermal patches. Provider organization business managers, healthcare administrators and investors will also benefit from this study.
Transdermal drug patches offer the advantages of ease of use, painlessness, disposability, control of drug delivery and avoidance of first-pass metabolism by the liver. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. Growth in demand for drug patches is being driven by several factors - factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2018.
Note: The Table of Contents has Been Edited for Brevity. For a Completed Version, Please Request a Free Sample.
Browse more Drug Delivery System Market Research Reports